InvestorsHub Logo
Followers 31
Posts 2142
Boards Moderated 0
Alias Born 01/09/2017

Re: berthabluefish1 post# 12031

Thursday, 06/14/2018 10:00:30 AM

Thursday, June 14, 2018 10:00:30 AM

Post# of 27409
Thanks Bert.

Copy n paste from that:

“Sepsis is the most expensive and deadliest condition we are battling in our hospitals. But when did you last see headlines trumpeting a blockbuster new sepsis drug? You haven’t — and you won’t — until we make a serious commitment to fight the oldest disease of all.

Derek C. Angus, M.D., is professor and chair of critical care medicine and director of the Clinical Research, Investigation, and Systems Modeling of Acute Illnesses Center at the University of Pittsburgh School of Medicine. He reports receiving grant support from the NIH and consulting fees from Bayer, Beckman Coulter, Biocartis, Bristol-Myers Squibb, Ferring, GenMark, GSK, and Sobi.”

Wouldn’t you think DR. Angus is aware of CTSO? And why does it have to be a drug? Perhaps another therapeutic avenue is safe, efficacious, and CURRENTLY saving lives.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News